Tapewire

Nasdaq · USD

WEN

Wendy's Co

Export transactions ↓
Tapewire entity
4659
SEC CIK
0000030697
Parsed reports
1,097

Last 12 months

Inside the activity.

2 purchase rows · 0 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202520
Dec 202500
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
January 03, 2025 Filed Jan 7, 2025 21:42 UTC
MAY PETER WDirector · 10% owner
GrantCommon Stock 1,880 $17.22 $32,373.60
Disclosure

SEC source: 0000950170-25-002906 · ownership.xml · nonDerivative · entry 1

MAY PETER W · CIK 0000928264 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,510,666

F1 · acquired: Shares were issued pursuant to the Company's 2020 Omnibus Award Plan (the "Plan") in lieu of a quarterly Board of Directors retainer fee and a quarterly Board committee retainer fee that would otherwise be payable in cash. In accordance with the Plan, the price is the average of the closing price per share on the 20 consecutive trading days immediately preceding the date on which the retainer fees would otherwise be payable.

Read SEC document
January 03, 2025 Filed Jan 7, 2025 21:42 UTC GrantCommon Stock 702 $17.22 $12,088.44
Disclosure

SEC source: 0001127602-25-000922 · form4.xml · nonDerivative · entry 1

Dolan Kristin A · CIK 0001480991 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 41,829

F1 · kind: Shares were issued pursuant to the Company's 2020 Omnibus Award Plan (the "Plan") in lieu of a portion of Ms. Dolan's quarterly Board of Directors retainer fee and quarterly Board committee retainer fees that would otherwise be payable in cash. In accordance with the Plan, the price is the average of the closing price per share on the 20 consecutive trading days immediately preceding the date on which the retainer fees would otherwise be payable.

Read SEC document
December 18, 2024 Filed Dec 19, 2024 22:02 UTC
Thuerk Suzanne M.Chief Accounting Officer
GrantRestricted Stock Units · Derivative 17,985 $0.00 $0.00
Disclosure

SEC source: 0001127602-24-029812 · form4.xml · derivative · entry 1

Thuerk Suzanne M. · CIK 0001963800 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 24,530

Underlying: Common Stock · 17,985 shares

Expires not disclosed

F1 · security: With tandem dividend equivalent rights and tax withholding rights.

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Company's common stock.

F3 · derivative.exercise_date: The restricted stock units will vest in full on December 18, 2027, subject to Ms. Thuerk's continued employment with the Company on the vesting date.

F3 · derivative.expiration_date: The restricted stock units will vest in full on December 18, 2027, subject to Ms. Thuerk's continued employment with the Company on the vesting date.

Read SEC document
December 16, 2024 Filed Dec 18, 2024 22:48 UTC GrantRestricted Stock Units · Derivative 436 $0.00 $0.00
Disclosure

SEC source: 0001127602-24-029746 · form4.xml · derivative · entry 6

Radkoski Lindsay J. · CIK 0002034276 · CMO, U.S.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 54,612

Underlying: Common Stock · 436 shares

Expires not disclosed

F1 · security: With tandem dividend equivalent rights and tax withholding rights.

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Company's common stock.

F3 · shares: Represents dividend equivalent units issued on December 16, 2024.

F9 · derivative.exercise_date: The restricted stock units will vest in full on August 15, 2027, subject to Ms. Radkoski's continued employment with the Company on the vesting date.

F9 · derivative.expiration_date: The restricted stock units will vest in full on August 15, 2027, subject to Ms. Radkoski's continued employment with the Company on the vesting date.

Read SEC document
December 16, 2024 Filed Dec 18, 2024 22:48 UTC GrantRestricted Stock Units · Derivative 110 $0.00 $0.00
Disclosure

SEC source: 0001127602-24-029746 · form4.xml · derivative · entry 5

Radkoski Lindsay J. · CIK 0002034276 · CMO, U.S.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 54,176

Underlying: Common Stock · 110 shares

Expires not disclosed

F1 · security: With tandem dividend equivalent rights and tax withholding rights.

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Company's common stock.

F3 · shares: Represents dividend equivalent units issued on December 16, 2024.

F8 · derivative.exercise_date: The restricted stock units will vest in three equal installments on August 15, 2025, 2026 and 2027, subject to Ms. Radkoski's continued employment with the Company on the applicable vesting date.

F8 · derivative.expiration_date: The restricted stock units will vest in three equal installments on August 15, 2025, 2026 and 2027, subject to Ms. Radkoski's continued employment with the Company on the applicable vesting date.

Read SEC document
December 16, 2024 Filed Dec 18, 2024 22:48 UTC GrantRestricted Stock Units · Derivative 43 $0.00 $0.00
Disclosure

SEC source: 0001127602-24-029746 · form4.xml · derivative · entry 4

Radkoski Lindsay J. · CIK 0002034276 · CMO, U.S.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 54,066

Underlying: Common Stock · 43 shares

Expires not disclosed

F1 · security: With tandem dividend equivalent rights and tax withholding rights.

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Company's common stock.

F3 · shares: Represents dividend equivalent units issued on December 16, 2024.

F7 · derivative.exercise_date: The restricted stock units will vest in three equal installments on August 5, 2025, 2026 and 2027, subject to Ms. Radkoski's continued employment with the Company on the applicable vesting date.

F7 · derivative.expiration_date: The restricted stock units will vest in three equal installments on August 5, 2025, 2026 and 2027, subject to Ms. Radkoski's continued employment with the Company on the applicable vesting date.

Read SEC document
December 16, 2024 Filed Dec 18, 2024 22:48 UTC GrantRestricted Stock Units · Derivative 121 $0.00 $0.00
Disclosure

SEC source: 0001127602-24-029746 · form4.xml · derivative · entry 3

Radkoski Lindsay J. · CIK 0002034276 · CMO, U.S.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 54,023

Underlying: Common Stock · 121 shares

Expires not disclosed

F1 · security: With tandem dividend equivalent rights and tax withholding rights.

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Company's common stock.

F3 · shares: Represents dividend equivalent units issued on December 16, 2024.

F6 · derivative.exercise_date: The restricted stock units will vest in three equal installments on December 7, 2024, 2025 and 2026, subject to Ms. Radkoski's continued employment with the Company on the applicable vesting date.

F6 · derivative.expiration_date: The restricted stock units will vest in three equal installments on December 7, 2024, 2025 and 2026, subject to Ms. Radkoski's continued employment with the Company on the applicable vesting date.

Read SEC document
December 16, 2024 Filed Dec 18, 2024 22:48 UTC GrantRestricted Stock Units · Derivative 16 $0.00 $0.00
Disclosure

SEC source: 0001127602-24-029746 · form4.xml · derivative · entry 2

Radkoski Lindsay J. · CIK 0002034276 · CMO, U.S.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 53,902

Underlying: Common Stock · 16 shares

Expires not disclosed

F1 · security: With tandem dividend equivalent rights and tax withholding rights.

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Company's common stock.

F3 · shares: Represents dividend equivalent units issued on December 16, 2024.

F5 · derivative.exercise_date: The restricted stock units will vest in two remaining equal installments on August 11, 2025 and 2026, subject to Ms. Radkoski's continued employment with the Company on the applicable vesting date.

F5 · derivative.expiration_date: The restricted stock units will vest in two remaining equal installments on August 11, 2025 and 2026, subject to Ms. Radkoski's continued employment with the Company on the applicable vesting date.

Read SEC document
December 16, 2024 Filed Dec 18, 2024 22:48 UTC GrantRestricted Stock Units · Derivative 69 $0.00 $0.00
Disclosure

SEC source: 0001127602-24-029746 · form4.xml · derivative · entry 1

Radkoski Lindsay J. · CIK 0002034276 · CMO, U.S.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 53,886

Underlying: Common Stock · 69 shares

Expires not disclosed

F1 · security: With tandem dividend equivalent rights and tax withholding rights.

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Company's common stock.

F3 · shares: Represents dividend equivalent units issued on December 16, 2024.

F4 · derivative.exercise_date: The restricted stock units will vest in full on August 12, 2025, subject to Ms. Radkoski's continued employment with the Company on the vesting date.

F4 · derivative.expiration_date: The restricted stock units will vest in full on August 12, 2025, subject to Ms. Radkoski's continued employment with the Company on the vesting date.

Read SEC document
December 16, 2024 Filed Dec 18, 2024 22:46 UTC GrantRestricted Stock Units · Derivative 138 $0.00 $0.00
Disclosure

SEC source: 0001127602-24-029744 · form4.xml · derivative · entry 2

GILBERT KENNETH W · CIK 0001120304 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,759

Underlying: Common Stock · 138 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Company's common stock.

F2 · shares: Represents dividend equivalent units issued on December 16, 2024.

F4 · derivative.exercise_date: The restricted stock units will vest in full on the earlier of May 21, 2025 or the date of the Company's 2025 annual meeting of stockholders. Vested shares will be delivered upon Mr. Gilbert's termination as a director of the Company.

F4 · derivative.expiration_date: The restricted stock units will vest in full on the earlier of May 21, 2025 or the date of the Company's 2025 annual meeting of stockholders. Vested shares will be delivered upon Mr. Gilbert's termination as a director of the Company.

Read SEC document
December 16, 2024 Filed Dec 18, 2024 22:46 UTC GrantRestricted Stock Units · Derivative 106 $0.00 $0.00
Disclosure

SEC source: 0001127602-24-029744 · form4.xml · derivative · entry 1

GILBERT KENNETH W · CIK 0001120304 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,621

Underlying: Common Stock · 106 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Company's common stock.

F2 · shares: Represents dividend equivalent units issued on December 16, 2024.

F3 · derivative.exercise_date: The restricted stock units vested in full on May 16, 2024. Vested shares will be delivered upon Mr. Gilbert's termination as a director of the Company.

F3 · derivative.expiration_date: The restricted stock units vested in full on May 16, 2024. Vested shares will be delivered upon Mr. Gilbert's termination as a director of the Company.

Read SEC document
December 16, 2024 Filed Dec 18, 2024 22:43 UTC
Tanner KirkDirector · President & CEO
GrantRestricted Stock Units · Derivative 809 $0.00 $0.00
Disclosure

SEC source: 0001127602-24-029742 · form4.xml · derivative · entry 2

Tanner Kirk · CIK 0001671693 · Director · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 408,985

Underlying: Common Stock · 809 shares

Expires not disclosed

F1 · security: With tandem dividend equivalent rights and tax withholding rights.

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Company's common stock.

F3 · shares: Represents dividend equivalent units issued on December 16, 2024.

F5 · derivative.exercise_date: The restricted stock units will vest in three equal installments on August 5, 2025, 2026 and 2027, subject to Mr. Tanner's continued employment with the Company on the applicable vesting date.

F5 · derivative.expiration_date: The restricted stock units will vest in three equal installments on August 5, 2025, 2026 and 2027, subject to Mr. Tanner's continued employment with the Company on the applicable vesting date.

Read SEC document
December 16, 2024 Filed Dec 18, 2024 22:43 UTC
Tanner KirkDirector · President & CEO
GrantRestricted Stock Units · Derivative 5,157 $0.00 $0.00
Disclosure

SEC source: 0001127602-24-029742 · form4.xml · derivative · entry 1

Tanner Kirk · CIK 0001671693 · Director · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 408,176

Underlying: Common Stock · 5,157 shares

Expires not disclosed

F1 · security: With tandem dividend equivalent rights and tax withholding rights.

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Company's common stock.

F3 · shares: Represents dividend equivalent units issued on December 16, 2024.

F4 · derivative.exercise_date: The restricted stock units will vest in full in three equal installments on February 22, 2025, 2026 and 2027, subject to Mr. Tanner's continued employment with the Company on the applicable vesting date.

F4 · derivative.expiration_date: The restricted stock units will vest in full in three equal installments on February 22, 2025, 2026 and 2027, subject to Mr. Tanner's continued employment with the Company on the applicable vesting date.

Read SEC document
December 16, 2024 Filed Dec 18, 2024 22:41 UTC GrantRestricted Stock Units · Derivative 138 $0.00 $0.00
Disclosure

SEC source: 0001127602-24-029740 · form4.xml · derivative · entry 1

Arlin Wendy C. · CIK 0001876592 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,513

Underlying: Common Stock · 138 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Company's common stock.

F2 · shares: Represents dividend equivalent units issued on December 16, 2024.

F3 · derivative.exercise_date: The restricted stock units will vest in full on the earlier of May 21, 2025 or the date of the Company's 2025 annual meeting of stockholders. Vested shares will be delivered upon Ms. Arlin's termination as a director of the Company.

F3 · derivative.expiration_date: The restricted stock units will vest in full on the earlier of May 21, 2025 or the date of the Company's 2025 annual meeting of stockholders. Vested shares will be delivered upon Ms. Arlin's termination as a director of the Company.

Read SEC document
December 16, 2024 Filed Dec 18, 2024 22:38 UTC
Esposito LilianaChf Corp Affrs & Sustnblty Ofc
GrantRestricted Stock Units · Derivative 91 $0.00 $0.00
Disclosure

SEC source: 0001127602-24-029738 · form4.xml · derivative · entry 2

Esposito Liliana · CIK 0001609772 · Chf Corp Affrs & Sustnblty Ofc

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,391

Underlying: Common Stock · 91 shares

Expires not disclosed

F1 · security: With tandem dividend equivalent rights and tax withholding rights.

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Company's common stock.

F3 · shares: Represents dividend equivalent units issued on December 16, 2024.

F5 · derivative.exercise_date: The restricted stock units will vest in three equal installments on August 5, 2025, 2026 and 2027 subject to Ms. Esposito's continued employment with the Company on the applicable vesting date.

F5 · derivative.expiration_date: The restricted stock units will vest in three equal installments on August 5, 2025, 2026 and 2027 subject to Ms. Esposito's continued employment with the Company on the applicable vesting date.

Read SEC document
December 16, 2024 Filed Dec 18, 2024 22:38 UTC
Esposito LilianaChf Corp Affrs & Sustnblty Ofc
GrantRestricted Stock Units · Derivative 46 $0.00 $0.00
Disclosure

SEC source: 0001127602-24-029738 · form4.xml · derivative · entry 1

Esposito Liliana · CIK 0001609772 · Chf Corp Affrs & Sustnblty Ofc

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,300

Underlying: Common Stock · 46 shares

Expires not disclosed

F1 · security: With tandem dividend equivalent rights and tax withholding rights.

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Company's common stock.

F3 · shares: Represents dividend equivalent units issued on December 16, 2024.

F4 · derivative.exercise_date: The restricted stock units will vest in two remaining equal installments on August 11, 2025 and 2026, subject to Ms. Esposito's continued employment with the Company on the applicable vesting date.

F4 · derivative.expiration_date: The restricted stock units will vest in two remaining equal installments on August 11, 2025 and 2026, subject to Ms. Esposito's continued employment with the Company on the applicable vesting date.

Read SEC document
December 16, 2024 Filed Dec 18, 2024 22:36 UTC
O'Brien Matthew ColeyChief People Officer
GrantRestricted Stock Units · Derivative 105 $0.00 $0.00
Disclosure

SEC source: 0001127602-24-029734 · form4.xml · derivative · entry 3

O'Brien Matthew Coley · CIK 0001732939 · Chief People Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 28,208

Underlying: Common Stock · 105 shares

Expires not disclosed

F1 · security: With tandem dividend equivalent rights and tax withholding rights.

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Company's common stock.

F3 · shares: Represents dividend equivalent units issued on December 16, 2024.

F6 · derivative.exercise_date: The restricted stock units will vest in three equal installments on August 5, 2025, 2026 and 2027, subject to Mr. O'Brien's continued employment with the Company on the applicable vesting date.

F6 · derivative.expiration_date: The restricted stock units will vest in three equal installments on August 5, 2025, 2026 and 2027, subject to Mr. O'Brien's continued employment with the Company on the applicable vesting date.

Read SEC document
December 16, 2024 Filed Dec 18, 2024 22:36 UTC
O'Brien Matthew ColeyChief People Officer
GrantRestricted Stock Units · Derivative 51 $0.00 $0.00
Disclosure

SEC source: 0001127602-24-029734 · form4.xml · derivative · entry 2

O'Brien Matthew Coley · CIK 0001732939 · Chief People Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 28,103

Underlying: Common Stock · 51 shares

Expires not disclosed

F1 · security: With tandem dividend equivalent rights and tax withholding rights.

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Company's common stock.

F3 · shares: Represents dividend equivalent units issued on December 16, 2024.

F5 · derivative.exercise_date: The restricted stock units will vest in two remaining equal installments on August 11, 2025 and 2026, subject to Mr. O'Brien's continued employment with the Company on the applicable vesting date.

F5 · derivative.expiration_date: The restricted stock units will vest in two remaining equal installments on August 11, 2025 and 2026, subject to Mr. O'Brien's continued employment with the Company on the applicable vesting date.

Read SEC document
December 16, 2024 Filed Dec 18, 2024 22:36 UTC
O'Brien Matthew ColeyChief People Officer
GrantRestricted Stock Units · Derivative 255 $0.00 $0.00
Disclosure

SEC source: 0001127602-24-029734 · form4.xml · derivative · entry 1

O'Brien Matthew Coley · CIK 0001732939 · Chief People Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 28,052

Underlying: Common Stock · 255 shares

Expires not disclosed

F1 · security: With tandem dividend equivalent rights and tax withholding rights.

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Company's common stock.

F3 · shares: Represents dividend equivalent units issued on December 16, 2024.

F4 · derivative.exercise_date: The restricted stock units will vest in full on March 1, 2026, subject to Mr. O'Brien's continued employment with the Company on the vesting date.

F4 · derivative.expiration_date: The restricted stock units will vest in full on March 1, 2026, subject to Mr. O'Brien's continued employment with the Company on the vesting date.

Read SEC document
December 16, 2024 Filed Dec 18, 2024 22:33 UTC
Pringle Abigail E.President, U.S.
GrantRestricted Stock Units · Derivative 263 $0.00 $0.00
Disclosure

SEC source: 0001127602-24-029732 · form4.xml · derivative · entry 2

Pringle Abigail E. · CIK 0001676101 · President, U.S.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 26,344

Underlying: Common Stock · 263 shares

Expires not disclosed

F1 · security: With tandem dividend equivalent rights and tax withholding rights.

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Company's common stock.

F3 · shares: Represents dividend equivalent units issued on December 16, 2024.

F5 · derivative.exercise_date: The restricted stock units will vest in three equal installments on August 5, 2025, 2026 and 2027, subject to Ms. Pringle's continued employment with the Company on the applicable vesting date.

F5 · derivative.expiration_date: The restricted stock units will vest in three equal installments on August 5, 2025, 2026 and 2027, subject to Ms. Pringle's continued employment with the Company on the applicable vesting date.

Read SEC document
December 16, 2024 Filed Dec 18, 2024 22:33 UTC
Pringle Abigail E.President, U.S.
GrantRestricted Stock Units · Derivative 121 $0.00 $0.00
Disclosure

SEC source: 0001127602-24-029732 · form4.xml · derivative · entry 1

Pringle Abigail E. · CIK 0001676101 · President, U.S.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 26,081

Underlying: Common Stock · 121 shares

Expires not disclosed

F1 · security: With tandem dividend equivalent rights and tax withholding rights.

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Company's common stock.

F3 · shares: Represents dividend equivalent units issued on December 16, 2024.

F4 · derivative.exercise_date: The restricted stock units will vest in two remaining equal installments on August 11, 2025 and 2026, subject to Ms. Pringle's continued employment with the Company on the applicable vesting date.

F4 · derivative.expiration_date: The restricted stock units will vest in two remaining equal installments on August 11, 2025 and 2026, subject to Ms. Pringle's continued employment with the Company on the applicable vesting date.

Read SEC document
December 16, 2024 Filed Dec 18, 2024 22:32 UTC
Spessard Matthew PChief Information Officer
GrantRestricted Stock Units · Derivative 47 $0.00 $0.00
Disclosure

SEC source: 0001127602-24-029730 · form4.xml · derivative · entry 2

Spessard Matthew P · CIK 0002014323 · Chief Information Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,370

Underlying: Common Stock · 47 shares

Expires not disclosed

F1 · security: With tandem dividend equivalent rights and tax withholding rights.

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Company's common stock.

F3 · shares: Represents dividend equivalent units issued on December 16, 2024.

F5 · derivative.exercise_date: The restricted stock units will vest in three equal installments on August 5, 2025, 2026 and 2027, subject to Mr. Spessard's continued employment with the Company on the applicable vesting date.

F5 · derivative.expiration_date: The restricted stock units will vest in three equal installments on August 5, 2025, 2026 and 2027, subject to Mr. Spessard's continued employment with the Company on the applicable vesting date.

Read SEC document
December 16, 2024 Filed Dec 18, 2024 22:32 UTC
Spessard Matthew PChief Information Officer
GrantRestricted Stock Units · Derivative 16 $0.00 $0.00
Disclosure

SEC source: 0001127602-24-029730 · form4.xml · derivative · entry 1

Spessard Matthew P · CIK 0002014323 · Chief Information Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,323

Underlying: Common Stock · 16 shares

Expires not disclosed

F1 · security: With tandem dividend equivalent rights and tax withholding rights.

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Company's common stock.

F3 · shares: Represents dividend equivalent units issued on December 16, 2024.

F4 · derivative.exercise_date: The restricted stock units will vest in two remaining equal installments on August 11, 2025 and 2026, subject to Mr. Spessard's continued employment with the Company on the applicable vesting date.

F4 · derivative.expiration_date: The restricted stock units will vest in two remaining equal installments on August 11, 2025 and 2026, subject to Mr. Spessard's continued employment with the Company on the applicable vesting date.

Read SEC document
December 16, 2024 Filed Dec 18, 2024 22:30 UTC
Thuerk Suzanne M.Chief Accounting Officer
GrantRestricted Stock Units · Derivative 27 $0.00 $0.00
Disclosure

SEC source: 0001127602-24-029728 · form4.xml · derivative · entry 3

Thuerk Suzanne M. · CIK 0001963800 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,545

Underlying: Common Stock · 27 shares

Expires not disclosed

F1 · security: With tandem dividend equivalent rights and tax withholding rights.

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Company's common stock.

F3 · shares: Represents dividend equivalent units issued on December 16, 2024.

F6 · derivative.exercise_date: The restricted stock units will vest in three equal installments on August 5, 2025, 2026 and 2027, subject to Ms. Thuerk's continued employment with the Company on the applicable vesting date.

F6 · derivative.expiration_date: The restricted stock units will vest in three equal installments on August 5, 2025, 2026 and 2027, subject to Ms. Thuerk's continued employment with the Company on the applicable vesting date.

Read SEC document
December 16, 2024 Filed Dec 18, 2024 22:30 UTC
Thuerk Suzanne M.Chief Accounting Officer
GrantRestricted Stock Units · Derivative 11 $0.00 $0.00
Disclosure

SEC source: 0001127602-24-029728 · form4.xml · derivative · entry 2

Thuerk Suzanne M. · CIK 0001963800 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,518

Underlying: Common Stock · 11 shares

Expires not disclosed

F1 · security: With tandem dividend equivalent rights and tax withholding rights.

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Company's common stock.

F3 · shares: Represents dividend equivalent units issued on December 16, 2024.

F5 · derivative.exercise_date: The restricted stock units will vest in two remaining equal installments on August 11, 2025 and 2026, subject to Ms. Thuerk's continued employment with the Company on the applicable vesting date.

F5 · derivative.expiration_date: The restricted stock units will vest in two remaining equal installments on August 11, 2025 and 2026, subject to Ms. Thuerk's continued employment with the Company on the applicable vesting date.

Read SEC document
December 16, 2024 Filed Dec 18, 2024 22:30 UTC
Thuerk Suzanne M.Chief Accounting Officer
GrantRestricted Stock Units · Derivative 57 $0.00 $0.00
Disclosure

SEC source: 0001127602-24-029728 · form4.xml · derivative · entry 1

Thuerk Suzanne M. · CIK 0001963800 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,507

Underlying: Common Stock · 57 shares

Expires not disclosed

F1 · security: With tandem dividend equivalent rights and tax withholding rights.

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Company's common stock.

F3 · shares: Represents dividend equivalent units issued on December 16, 2024.

F4 · derivative.exercise_date: The restricted stock units will vest in full on August 12, 2025, subject to Ms. Thuerk's continued employment with the Company on the vesting date.

F4 · derivative.expiration_date: The restricted stock units will vest in full on August 12, 2025, subject to Ms. Thuerk's continued employment with the Company on the vesting date.

Read SEC document
December 16, 2024 Filed Dec 18, 2024 22:28 UTC
Wunsch E.J.President, International
GrantRestricted Stock Units · Derivative 219 $0.00 $0.00
Disclosure

SEC source: 0001127602-24-029726 · form4.xml · derivative · entry 2

Wunsch E.J. · CIK 0001685884 · President, International

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,567

Underlying: Common Stock · 219 shares

Expires not disclosed

F1 · security: With tandem dividend equivalent rights and tax withholding rights.

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Company's common stock.

F3 · shares: Represents dividend equivalent units issued on December 16, 2024.

F5 · derivative.exercise_date: The restricted stock units will vest in three equal installments on August 5, 2025, 2026 and 2027, subject to Mr. Wunsch's continued employment with the Company on the applicable vesting date.

F5 · derivative.expiration_date: The restricted stock units will vest in three equal installments on August 5, 2025, 2026 and 2027, subject to Mr. Wunsch's continued employment with the Company on the applicable vesting date.

Read SEC document
December 16, 2024 Filed Dec 18, 2024 22:28 UTC
Wunsch E.J.President, International
GrantRestricted Stock Units · Derivative 81 $0.00 $0.00
Disclosure

SEC source: 0001127602-24-029726 · form4.xml · derivative · entry 1

Wunsch E.J. · CIK 0001685884 · President, International

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,348

Underlying: Common Stock · 81 shares

Expires not disclosed

F1 · security: With tandem dividend equivalent rights and tax withholding rights.

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Company's common stock.

F3 · shares: Represents dividend equivalent units issued on December 16, 2024.

F4 · derivative.exercise_date: The restricted stock units will vest in two remaining equal installments on August 11, 2025 and 2026, subject to Mr. Wunsch's continued employment with the Company on the applicable vesting date.

F4 · derivative.expiration_date: The restricted stock units will vest in two remaining equal installments on August 11, 2025 and 2026, subject to Mr. Wunsch's continued employment with the Company on the applicable vesting date.

Read SEC document
December 16, 2024 Filed Dec 18, 2024 22:26 UTC
Min JohnChief Legal Ofcr & Secretary
GrantRestricted Stock Units · Derivative 208 $0.00 $0.00
Disclosure

SEC source: 0001127602-24-029724 · form4.xml · derivative · entry 1

Min John · CIK 0001994515 · Chief Legal Ofcr & Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,308

Underlying: Common Stock · 208 shares

Expires not disclosed

F1 · security: With tandem dividend equivalent rights and tax withholding rights.

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Company's common stock.

F3 · shares: Represents dividend equivalent units issued on December 16, 2024.

F4 · derivative.exercise_date: The restricted stock units will vest in full on September 16, 2027, subject to Mr. Min's continued employment with the Company on the vesting date.

F4 · derivative.expiration_date: The restricted stock units will vest in full on September 16, 2027, subject to Mr. Min's continued employment with the Company on the vesting date.

Read SEC document
December 16, 2024 Filed Dec 18, 2024 22:24 UTC
Cook Kenneth M.Chief Financial Officer
GrantRestricted Stock Units · Derivative 245 $0.00 $0.00
Disclosure

SEC source: 0001127602-24-029722 · form4.xml · derivative · entry 1

Cook Kenneth M. · CIK 0002046945 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,856

Underlying: Common Stock · 245 shares

Expires not disclosed

F1 · security: With tandem dividend equivalent rights and tax withholding rights.

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Company's common stock.

F3 · shares: Represents dividend equivalent units issued on December 16, 2024.

F4 · derivative.exercise_date: The restricted stock units will vest in full on December 2, 2027, subject to Mr. Cook's continued employment with the Company on the vesting date.

F4 · derivative.expiration_date: The restricted stock units will vest in full on December 2, 2027, subject to Mr. Cook's continued employment with the Company on the vesting date.

Read SEC document
December 02, 2024 Filed Dec 4, 2024 21:56 UTC
Cook Kenneth M.Chief Financial Officer
GrantRestricted Stock Units · Derivative 16,611 $0.00 $0.00
Disclosure

SEC source: 0001127602-24-028651 · form4.xml · derivative · entry 1

Cook Kenneth M. · CIK 0002046945 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,611

Underlying: Common Stock · 16,611 shares

Expires not disclosed

F1 · security: With tandem dividend equivalent rights and tax withholding rights.

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Company's common stock.

F3 · derivative.exercise_date: The restricted stock units will vest in full on December 2, 2027, subject to Mr. Cook's continued employment with the Company on the vesting date.

F3 · derivative.expiration_date: The restricted stock units will vest in full on December 2, 2027, subject to Mr. Cook's continued employment with the Company on the vesting date.

Read SEC document
November 07, 2024 Filed Nov 8, 2024 21:46 UTC SaleCommon Stock 24,462 $20.28 $496,089.36
Disclosure

SEC source: 0001127602-24-026851 · form4.xml · nonDerivative · entry 1

Mathews-Spradlin Mich J · CIK 0001635074 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 63,789

Read SEC document
November 05, 2024 Filed Nov 7, 2024 22:02 UTC
Esposito LilianaChf Corp Affrs & Sustnblty Ofc
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative 52,009 $0.00 Strike: $15.36 $0.00
Disclosure

SEC source: 0001127602-24-026738 · form4.xml · derivative · entry 3

Esposito Liliana · CIK 0001609772 · Chf Corp Affrs & Sustnblty Ofc

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 52,009 shares

Expires 2027-08-11

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: With tandem net exercise and tax withholding rights.

F2 · derivative.exercise_date: The option vested in three equal installments on August 11, 2018, 2019 and 2020 and is currently exercisable as to all 52,009 remaining shares.

Read SEC document
November 05, 2024 Filed Nov 7, 2024 22:02 UTC
Esposito LilianaChf Corp Affrs & Sustnblty Ofc
SaleCommon Stock 52,009 $19.63 $1,020,936.67
Disclosure

SEC source: 0001127602-24-026738 · form4.xml · nonDerivative · entry 2

Esposito Liliana · CIK 0001609772 · Chf Corp Affrs & Sustnblty Ofc

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 83,492

Read SEC document
November 05, 2024 Filed Nov 7, 2024 22:02 UTC
Esposito LilianaChf Corp Affrs & Sustnblty Ofc
Exercise / conversionCommon Stock 52,009 $15.36 $798,598.20
Disclosure

SEC source: 0001127602-24-026738 · form4.xml · nonDerivative · entry 1

Esposito Liliana · CIK 0001609772 · Chf Corp Affrs & Sustnblty Ofc

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 135,501

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
October 03, 2024 Filed Oct 7, 2024 20:46 UTC GrantCommon Stock 813 $17.28 $14,048.64
Disclosure

SEC source: 0001127602-24-025290 · form4.xml · nonDerivative · entry 1

Dolan Kristin A · CIK 0001480991 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 41,127

F1 · kind: Shares were issued pursuant to the Company's 2020 Omnibus Award Plan (the "Plan") in lieu of a portion of Ms. Dolan's quarterly Board of Directors retainer fee and quarterly Board committee retainer fees that would otherwise be payable in cash. In accordance with the Plan, the price is the average of the closing price per share on the 20 consecutive trading days immediately preceding the date on which the retainer fees would otherwise be payable.

Read SEC document
October 03, 2024 Filed Oct 7, 2024 20:46 UTC
Peltz Matthew H.Director · 10% owner
GrantCommon Stock 1,569 $17.28 $27,112.32
Disclosure

SEC source: 0000950170-24-113274 · ownership.xml · nonDerivative · entry 1

Peltz Matthew H. · CIK 0001661127 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 112,334

F1 · acquired: Shares were issued pursuant to the Company's 2020 Omnibus Award Plan (the "Plan") in lieu of a quarterly Board of Directors retainer fee and a quarterly Board committee retainer fee that would otherwise be payable in cash. In accordance with the Plan, the price is the average of the closing price per share on the 20 consecutive trading days immediately preceding the date on which the retainer fees would otherwise be payable.

Read SEC document
October 03, 2024 Filed Oct 7, 2024 20:45 UTC
MAY PETER WDirector · 10% owner
GrantCommon Stock 1,757 $17.28 $30,360.96
Disclosure

SEC source: 0000950170-24-113268 · ownership.xml · nonDerivative · entry 1

MAY PETER W · CIK 0000928264 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,508,786

F1 · acquired: Shares were issued pursuant to the Company's 2020 Omnibus Award Plan (the "Plan") in lieu of a quarterly Board of Directors retainer fee and a quarterly Board committee retainer fee that would otherwise be payable in cash. In accordance with the Plan, the price is the average of the closing price per share on the 20 consecutive trading days immediately preceding the date on which the retainer fees would otherwise be payable.

Read SEC document
September 17, 2024 Filed Sep 19, 2024 21:01 UTC
Esposito LilianaChf Corp Affrs & Sustnblty Ofc
GrantRestricted Stock Units · Derivative 85 $0.00 $0.00
Disclosure

SEC source: 0001127602-24-024257 · form4.xml · derivative · entry 2

Esposito Liliana · CIK 0001609772 · Chf Corp Affrs & Sustnblty Ofc

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,254

Underlying: Common Stock · 85 shares

Expires not disclosed

F1 · security: With tandem dividend equivalent rights and tax withholding rights.

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Company's common stock.

F3 · shares: Represents dividend equivalent units issued on September 17, 2024.

F5 · derivative.exercise_date: The restricted stock units will vest in three equal installments on August 5, 2025, 2026 and 2027, subject to Ms. Esposito's continued employment with the Company on the applicable vesting date.

F5 · derivative.expiration_date: The restricted stock units will vest in three equal installments on August 5, 2025, 2026 and 2027, subject to Ms. Esposito's continued employment with the Company on the applicable vesting date.

Read SEC document
September 17, 2024 Filed Sep 19, 2024 21:01 UTC
Esposito LilianaChf Corp Affrs & Sustnblty Ofc
GrantRestricted Stock Units · Derivative 43 $0.00 $0.00
Disclosure

SEC source: 0001127602-24-024257 · form4.xml · derivative · entry 1

Esposito Liliana · CIK 0001609772 · Chf Corp Affrs & Sustnblty Ofc

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,169

Underlying: Common Stock · 43 shares

Expires not disclosed

F1 · security: With tandem dividend equivalent rights and tax withholding rights.

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Company's common stock.

F3 · shares: Represents dividend equivalent units issued on September 17, 2024.

F4 · derivative.exercise_date: The restricted stock units will vest in two remaining equal installments on August 11, 2025 and 2026, subject to Ms. Esposito's continued employment with the Company on the applicable vesting date.

F4 · derivative.expiration_date: The restricted stock units will vest in two remaining equal installments on August 11, 2025 and 2026, subject to Ms. Esposito's continued employment with the Company on the applicable vesting date.

Read SEC document
September 17, 2024 Filed Sep 19, 2024 20:59 UTC
Plosch GuntherChief Financial Officer
GrantRestricted Stock Units · Derivative 240 $0.00 $0.00
Disclosure

SEC source: 0001127602-24-024255 · form4.xml · derivative · entry 2

Plosch Gunther · CIK 0001673498 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 26,497

Underlying: Common Stock · 240 shares

Expires not disclosed

F1 · security: With tandem dividend equivalent rights and tax withholding rights.

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Company's common stock.

F3 · shares: Represents dividend equivalent units issued on September 17, 2024.

F5 · derivative.exercise_date: The restricted stock units will vest in full in three equal installments on August 5, 2025, 2026 and 2027 subject to Mr. Plosch's continued employment with the Company on the applicable vesting date.

F5 · derivative.expiration_date: The restricted stock units will vest in full in three equal installments on August 5, 2025, 2026 and 2027 subject to Mr. Plosch's continued employment with the Company on the applicable vesting date.

Read SEC document
September 17, 2024 Filed Sep 19, 2024 20:59 UTC
Plosch GuntherChief Financial Officer
GrantRestricted Stock Units · Derivative 128 $0.00 $0.00
Disclosure

SEC source: 0001127602-24-024255 · form4.xml · derivative · entry 1

Plosch Gunther · CIK 0001673498 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 26,257

Underlying: Common Stock · 128 shares

Expires not disclosed

F1 · security: With tandem dividend equivalent rights and tax withholding rights.

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Company's common stock.

F3 · shares: Represents dividend equivalent units issued on September 17, 2024.

F4 · derivative.exercise_date: The restricted stock units will vest in two remaining equal installments on August 11, 2025 and 2026, subject to Mr. Plosch's continued employment with the Company on the applicable vesting date.

F4 · derivative.expiration_date: The restricted stock units will vest in two remaining equal installments on August 11, 2025 and 2026, subject to Mr. Plosch's continued employment with the Company on the applicable vesting date.

Read SEC document
September 17, 2024 Filed Sep 19, 2024 21:00 UTC
O'Brien Matthew ColeyChief People Officer
GrantRestricted Stock Units · Derivative 97 $0.00 $0.00
Disclosure

SEC source: 0001127602-24-024256 · form4.xml · derivative · entry 3

O'Brien Matthew Coley · CIK 0001732939 · Chief People Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 27,797

Underlying: Common Stock · 97 shares

Expires not disclosed

F1 · security: With tandem dividend equivalent rights and tax withholding rights.

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Company's common stock.

F3 · shares: Represents dividend equivalent units issued on September 17, 2024.

F6 · derivative.exercise_date: The restricted stock units will vest in three equal installments on August 5, 2025, 2026 and 2027, subject to Mr. O'Brien's continued employment with the Company on the applicable vesting date.

F6 · derivative.expiration_date: The restricted stock units will vest in three equal installments on August 5, 2025, 2026 and 2027, subject to Mr. O'Brien's continued employment with the Company on the applicable vesting date.

Read SEC document
September 17, 2024 Filed Sep 19, 2024 21:00 UTC
O'Brien Matthew ColeyChief People Officer
GrantRestricted Stock Units · Derivative 48 $0.00 $0.00
Disclosure

SEC source: 0001127602-24-024256 · form4.xml · derivative · entry 2

O'Brien Matthew Coley · CIK 0001732939 · Chief People Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 27,700

Underlying: Common Stock · 48 shares

Expires not disclosed

F1 · security: With tandem dividend equivalent rights and tax withholding rights.

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Company's common stock.

F3 · shares: Represents dividend equivalent units issued on September 17, 2024.

F5 · derivative.exercise_date: The restricted stock units will vest in two remaining equal installments on August 11, 2025 and 2026, subject to Mr. O'Brien's continued employment with the Company on the applicable vesting date.

F5 · derivative.expiration_date: The restricted stock units will vest in two remaining equal installments on August 11, 2025 and 2026, subject to Mr. O'Brien's continued employment with the Company on the applicable vesting date.

Read SEC document
September 17, 2024 Filed Sep 19, 2024 21:00 UTC
O'Brien Matthew ColeyChief People Officer
GrantRestricted Stock Units · Derivative 240 $0.00 $0.00
Disclosure

SEC source: 0001127602-24-024256 · form4.xml · derivative · entry 1

O'Brien Matthew Coley · CIK 0001732939 · Chief People Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 27,652

Underlying: Common Stock · 240 shares

Expires not disclosed

F1 · security: With tandem dividend equivalent rights and tax withholding rights.

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Company's common stock.

F3 · shares: Represents dividend equivalent units issued on September 17, 2024.

F4 · derivative.exercise_date: The restricted stock units will vest in full on March 1, 2026, subject to Mr. O'Brien's continued employment with the Company on the vesting date.

F4 · derivative.expiration_date: The restricted stock units will vest in full on March 1, 2026, subject to Mr. O'Brien's continued employment with the Company on the vesting date.

Read SEC document
September 17, 2024 Filed Sep 19, 2024 20:58 UTC
Pringle Abigail E.President, U.S.
GrantRestricted Stock Units · Derivative 246 $0.00 $0.00
Disclosure

SEC source: 0001127602-24-024254 · form4.xml · derivative · entry 2

Pringle Abigail E. · CIK 0001676101 · President, U.S.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,960

Underlying: Common Stock · 246 shares

Expires not disclosed

F1 · security: With tandem dividend equivalent rights and tax withholding rights.

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Company's common stock.

F3 · shares: Represents dividend equivalent units issued on September 17, 2024.

F5 · derivative.exercise_date: The restricted stock units will vest in three equal installments on August 5, 2025, 2026 and 2027, subject to Ms. Pringle's continued employment with the Company on the applicable vesting date.

F5 · derivative.expiration_date: The restricted stock units will vest in three equal installments on August 5, 2025, 2026 and 2027, subject to Ms. Pringle's continued employment with the Company on the applicable vesting date.

Read SEC document
September 17, 2024 Filed Sep 19, 2024 20:58 UTC
Pringle Abigail E.President, U.S.
GrantRestricted Stock Units · Derivative 114 $0.00 $0.00
Disclosure

SEC source: 0001127602-24-024254 · form4.xml · derivative · entry 1

Pringle Abigail E. · CIK 0001676101 · President, U.S.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,714

Underlying: Common Stock · 114 shares

Expires not disclosed

F1 · security: With tandem dividend equivalent rights and tax withholding rights.

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Company's common stock.

F3 · shares: Represents dividend equivalent units issued on September 17, 2024.

F4 · derivative.exercise_date: The restricted stock units will vest in two remaining equal installments on August 11, 2025 and 2026, subject to Ms. Pringle's continued employment with the Company on the applicable vesting date.

F4 · derivative.expiration_date: The restricted stock units will vest in two remaining equal installments on August 11, 2025 and 2026, subject to Ms. Pringle's continued employment with the Company on the applicable vesting date.

Read SEC document
September 17, 2024 Filed Sep 19, 2024 20:56 UTC GrantRestricted Stock Units · Derivative 409 $0.00 $0.00
Disclosure

SEC source: 0001127602-24-024253 · form4.xml · derivative · entry 6

Radkoski Lindsay J. · CIK 0002034276 · CMO, U.S.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 53,817

Underlying: Common Stock · 409 shares

Expires not disclosed

F1 · security: With tandem dividend equivalent rights and tax withholding rights.

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Company's common stock.

F3 · shares: Represents dividend equivalent units issued on September 17, 2024.

F9 · derivative.exercise_date: The restricted stock units will vest in full on August 15, 2027, subject to Ms. Radkoski's continued employment with the Company on the vesting date.

F9 · derivative.expiration_date: The restricted stock units will vest in full on August 15, 2027, subject to Ms. Radkoski's continued employment with the Company on the vesting date.

Read SEC document
September 17, 2024 Filed Sep 19, 2024 20:56 UTC GrantRestricted Stock Units · Derivative 102 $0.00 $0.00
Disclosure

SEC source: 0001127602-24-024253 · form4.xml · derivative · entry 5

Radkoski Lindsay J. · CIK 0002034276 · CMO, U.S.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 53,408

Underlying: Common Stock · 102 shares

Expires not disclosed

F1 · security: With tandem dividend equivalent rights and tax withholding rights.

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Company's common stock.

F3 · shares: Represents dividend equivalent units issued on September 17, 2024.

F8 · derivative.exercise_date: The restricted stock units will vest in three equal installments on August 15, 2025, 2026 and 2027, subject to Ms. Radkoski's continued employment with the Company on the applicable vesting date.

F8 · derivative.expiration_date: The restricted stock units will vest in three equal installments on August 15, 2025, 2026 and 2027, subject to Ms. Radkoski's continued employment with the Company on the applicable vesting date.

Read SEC document
September 17, 2024 Filed Sep 19, 2024 20:56 UTC GrantRestricted Stock Units · Derivative 41 $0.00 $0.00
Disclosure

SEC source: 0001127602-24-024253 · form4.xml · derivative · entry 4

Radkoski Lindsay J. · CIK 0002034276 · CMO, U.S.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 53,306

Underlying: Common Stock · 41 shares

Expires not disclosed

F1 · security: With tandem dividend equivalent rights and tax withholding rights.

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Company's common stock.

F3 · shares: Represents dividend equivalent units issued on September 17, 2024.

F7 · derivative.exercise_date: The restricted stock units will vest in three equal installments on August 5, 2025, 2026 and 2027, subject to Ms. Radkoski's continued employment with the Company on the applicable vesting date.

F7 · derivative.expiration_date: The restricted stock units will vest in three equal installments on August 5, 2025, 2026 and 2027, subject to Ms. Radkoski's continued employment with the Company on the applicable vesting date.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.